Endogenous treatment with PCSK9 inhibitors for Hyperlipidemia –of interest to Dr. Pearlman 1,2,3,4 abovecould be Therapeutic CONCEPTS ofCLS Therapeutics PLATFORMfor other indications thanoncologyand may have potential for a NEW venture that will license PATENT protected IP from CLS Therapeutics 1PM ...
Malpractice claims, active lawsuits, dental license issues, and background check concerns Equipment loans and liens Outstanding bills, invoices, and/or credit balances Personality conflicts Lack of empathy about what will happen with the team post-sale Out-of-date technology Poor website fun...